Thomas Lienard
Direktor/Vorstandsmitglied bei ANTIGON SA
Profil
Thomas Lienard is currently a Director at Antigon SA since 2020.
Prior to this, he was the Chief Executive Officer, MD & Executive Director at Bone Therapeutics SA from 2016 to 2020.
He also held positions as Sales Director at Eli Lilly Benelux SA, Managing Director at Lundbeck SA, and Director at Prométhéa Asbl.
Mr. Lienard received an MBA from Harvard Business School in 2004 and a graduate degree from Solvay Business School of Economics & Management in 1999.
Aktive Positionen von Thomas Lienard
| Unternehmen | Position | Beginn |
|---|---|---|
ANTIGON SA
 ANTIGON SA Medical SpecialtiesHealth Technology Antigon SA is a Belgian medical information company that provides information on weight loss medications such as Saxenda, Ozempic, Wegovy, Rybelsus, Xenical, Mysimba, and Victoza. The company is based in Charleroi, Belgium. The company allows customers to buy these medications online with a medical prescription validated by doctors and have them delivered to their homes within 24 hours. Antigon was founded in 2016 by Francis Corazza, Hanane El Kenz, and Thierry Baltus. | Direktor/Vorstandsmitglied | 01.07.2020 |
Ehemalige bekannte Positionen von Thomas Lienard
| Unternehmen | Position | Ende |
|---|---|---|
| BIOSENIC SA | Vorstandsvorsitzender | 01.01.2020 |
Eli Lilly Benelux SA
 Eli Lilly Benelux SA Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Benelux SA is a pharmaceutical company based in Brussels, Belgium. The Belgian company focuses on research and development to discover and offer innovative medicines that improve the quality of life for people worldwide. Lilly has established policies, standards, and protective measures for the entire research and development process to ensure that the patient remains the top priority. The CEO of the company is Frederic Clais. | Vertrieb & Marketing | - |
| Prométhéa Asbl | Direktor/Vorstandsmitglied | - |
Lundbeck SA
 Lundbeck SA Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck SA is a Belgian company founded in 2000. The company is based in Brussels, Belgium. The company's description mentions that a migraine attack is a severe headache, usually present with other symptoms, that stops a person from going about their daily life. | Vorstandsvorsitzender | - |
Ausbildung von Thomas Lienard
| Harvard Business School | Masters Business Admin |
| Solvay Business School of Economics & Management | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Eli Lilly Benelux SA
Eli Lilly Benelux SA Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Benelux SA is a pharmaceutical company based in Brussels, Belgium. The Belgian company focuses on research and development to discover and offer innovative medicines that improve the quality of life for people worldwide. Lilly has established policies, standards, and protective measures for the entire research and development process to ensure that the patient remains the top priority. The CEO of the company is Frederic Clais. | Health Technology |
Bone Therapeutics SA
 Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium. | Health Technology |
Lundbeck SA
Lundbeck SA Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck SA is a Belgian company founded in 2000. The company is based in Brussels, Belgium. The company's description mentions that a migraine attack is a severe headache, usually present with other symptoms, that stops a person from going about their daily life. | Health Technology |
| Prométhéa Asbl | |
ANTIGON SA
ANTIGON SA Medical SpecialtiesHealth Technology Antigon SA is a Belgian medical information company that provides information on weight loss medications such as Saxenda, Ozempic, Wegovy, Rybelsus, Xenical, Mysimba, and Victoza. The company is based in Charleroi, Belgium. The company allows customers to buy these medications online with a medical prescription validated by doctors and have them delivered to their homes within 24 hours. Antigon was founded in 2016 by Francis Corazza, Hanane El Kenz, and Thierry Baltus. | Health Technology |